Invivyd, Inc. advances VYD2311 as a Covid-19 vaccine alternative. Learn about upcoming trials and market opportunities. Click ...
Vaccination during pregnancy shows about 70% to 80% effectiveness in protecting newborns through antibody transfer. For adults over 60, vaccines demonstrate roughly 75% real-world effectiveness ...
Third Quarter 2025 Financial Results: Total revenue for the quarter ended September 30, 2025 was $134.2 million, up 12% from $119.8 million in the same period of 2024. This growth and operational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback